Search

Your search keyword '"Streptococcus pyogenes metabolism"' showing total 1,227 results

Search Constraints

Start Over You searched for: Descriptor "Streptococcus pyogenes metabolism" Remove constraint Descriptor: "Streptococcus pyogenes metabolism"
1,227 results on '"Streptococcus pyogenes metabolism"'

Search Results

1. Combining molecular modelling and experimental approaches to gain mechanistic insights into the LuxP drug target in Streptococcus pyogens .

2. M proteins of group A Streptococcus bind hyaluronic acid via arginine-arginine/serine-arginine motifs.

3. The double-edged role of FASII regulator FabT in Streptococcus pyogenes infection.

4. A genome-scale metabolic model of a globally disseminated hyperinvasive M1 strain of Streptococcus pyogenes .

5. Bioinformatics comparison of hemolysin in different bacteria and experimental evaluation of anti-cancer properties of extracts of some hemolysin-producing bacteria.

6. Capsule-deficient group A Streptococcus evades autophagy-mediated killing in macrophages.

7. Manganese uptake by MtsABC contributes to the pathogenesis of human pathogen group A streptococcus by resisting host nutritional immune defenses.

8. Generation of tools for expression and purification of the phage-encoded Type I restriction enzyme inhibitor, Ocr.

9. Conservation of C4BP-binding sequence patterns in Streptococcus pyogenes M and Enn proteins.

10. The Streptococcus pyogenes stand-alone regulator RofA exhibits characteristics of a PRD-containing virulence regulator.

11. Streptococcus pyogenes Cas9 ribonucleoprotein delivery for efficient, rapid and marker-free gene editing in Trypanosoma and Leishmania.

12. Quantification of Adaptive Immune Responses Against Protein-Binding Interfaces in the Streptococcal M1 Protein.

13. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9.

14. Streptolysin S is required for Streptococcus pyogenes nasopharyngeal and skin infection in HLA-transgenic mice.

15. Group A Streptococcus adaptation to diverse niches: lessons from transcriptomic studies.

16. Molecular characterization of the interaction between human IgG and the M-related proteins from Streptococcus pyogenes.

17. Group A Streptococcus interactions with the host across time and space.

18. Streptococcal pyrogenic exotoxin B is a superantigen that induces murine splenocyte proliferation and secretion of IL-2 and IFN-γ ex vivo.

19. Characterization of the RofA regulon in the pandemic M1 global and emergent M1 UK lineages of Streptococcus pyogenes .

20. Structure-activity studies of Streptococcus pyogenes enzyme SpyCEP reveal high affinity for CXCL8 in the SpyCEP C-terminal.

21. IdeS, a secreted proteinase of Streptococcus pyogenes, is bound to a nuclease at the bacterial surface where it inactivates opsonizing IgG antibodies.

22. Shifted PAMs generate DNA overhangs and enhance SpCas9 post-catalytic complex dissociation.

23. Acyl-AcpB, a FabT corepressor in Streptococcus pyogenes .

24. SIgA structures bound to Streptococcus pyogenes M4 and human CD89 provide insights into host-pathogen interactions.

25. Group A Streptococcus cation diffusion facilitator proteins contribute to immune evasion by regulating intracellular metal concentrations.

26. Impact of Propeptide Cleavage on the Stability and Activity of a Streptococcal Immunomodulatory C5a Peptidase for Biopharmaceutical Development.

27. Acyl Homoserine Lactone Sensitised Streptococcus Pyogenes Differentially Regulates the Transcriptional Expression of Early Growth Response 1 (EGR1) in Epithelial and Macrophage Cells.

28. Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A Streptococcus.

29. Involvement of ribonuclease Y in pilus production by M49 Streptococcus pyogenes strain via modulation of messenger RNA level of transcriptional regulator.

30. Central carbon flux controls growth/damage balance for Streptococcus pyogenes.

31. Hyperphosphorylation of the Group A Streptococcal Control of Virulence Regulator Increases Promoter Occupancy Specifically at Virulence Factor-Encoding Genes.

32. Position-dependent sequence motif preferences of SpCas9 are largely determined by scaffold-complementary spacer motifs.

33. Generation and characterization of a plasminogen-binding group A streptococcal M-protein/streptokinase-sensitive mouse line.

34. A Streptococcus pyogenes DegV protein regulates the membrane lipid content and limits the formation of extracellular vesicles.

35. A Novel CovS Variant Harbored by a Colonization Strain Reduces Streptococcus pyogenes Virulence.

36. RopB represses the transcription of speB in the absence of SIP in group A Streptococcus .

37. The role of CopA in Streptococcus pyogenes copper homeostasis and virulence.

38. Human serum albumin stabilizes streptolysin S activity secreted in the extracellular milieu by streptolysin S-producing streptococci.

39. Plausible Role of NLRP3 Inflammasome and Associated Cytokines in Pathogenesis of Rheumatic Heart Disease.

40. Elucidating the Stoichiometries of Host-Pathogen Protein Interactions with Mass Photometry.

41. Methods to Analyze the Contribution of Complement Evasion Factor (CEF) to Streptococcus pyogenes Virulence.

42. Detection of Inflammasome Activation in Murine Bone Marrow-Derived Macrophages Infected with Group A Streptococcus.

43. Promiscuous evolution of Group A Streptococcal M and M-like proteins.

44. Exploring and engineering PAM-diverse Streptococci Cas9 for PAM-directed bifunctional and titratable gene control in bacteria.

45. Extensive substrate recognition by the streptococcal antibody-degrading enzymes IdeS and EndoS.

46. The Streptococcus pyogenes hyaluronic acid capsule promotes experimental nasal and skin infection by preventing neutrophil-mediated clearance.

47. The Proteomic and Transcriptomic Landscapes Altered by Rgg2/3 Activity in Streptococcus pyogenes.

48. Expression of the Group A Streptococcus Fibrinogen-Binding Protein Mrp Is Negatively Regulated by the Small Regulatory RNA FasX.

49. Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells.

50. Streptococcus pyogenes can support or inhibit growth of Haemophilus influenzae by supplying or restricting extracellular NAD.

Catalog

Books, media, physical & digital resources